The tumor spectrum developed by p21Cip1/Waf deficient mice is remarkably similar to the one observed in p53 deficient mice, which is not surprising keeping in mind the p21Cip1/Waf activation by p53. This evidence concerns the gene CDKN1A and neoplasm.